Minimally invasive robot-B (02252) fell by more than 3%. As of press release, it was down 3.09% to HK$13.8 million, with a turnover of HK$5.87,800.
The Zhitong Finance App learned that minimally invasive robot-B (02252) fell by more than 3%. As of press release, it fell 3.09% to HK$13.8, with a turnover of HK$5.847,800.
According to the news, Minimally Invasive Robotics announced that the net loss for 2023 is expected to be no more than 1.05 billion yuan, compared to the previous year, of 1,146 billion yuan. The decrease in losses was mainly due to an increase in gross profit due to an increase in operating income; and a decrease in R&D expenses due to the focus on core R&D projects and improving R&D efficiency.
In addition, the company expects revenue to increase by more than 350% year-on-year in 2023. This increase is mainly due to the continuous increase in sales revenue due to the comprehensive commercialization process of the group's products Tumai four-arm endoscopic surgery robot, Honghu joint replacement surgery robot, and Dragonfly Eye 3D electronic laparoscopy.